PMC:7161517 / 23165-24318 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T138","span":{"begin":185,"end":195},"obj":"Body_part"},{"id":"T139","span":{"begin":185,"end":193},"obj":"Body_part"},{"id":"T140","span":{"begin":208,"end":215},"obj":"Body_part"}],"attributes":[{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma62340"},{"id":"A139","pred":"fma_id","subj":"T139","obj":"http://purl.org/sig/ont/fma/fma62338"},{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T101","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"T102","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"T103","span":{"begin":288,"end":294},"obj":"Disease"},{"id":"T104","span":{"begin":481,"end":523},"obj":"Disease"},{"id":"T105","span":{"begin":502,"end":523},"obj":"Disease"},{"id":"T106","span":{"begin":584,"end":600},"obj":"Disease"},{"id":"T107","span":{"begin":646,"end":654},"obj":"Disease"},{"id":"T108","span":{"begin":711,"end":717},"obj":"Disease"},{"id":"T109","span":{"begin":752,"end":762},"obj":"Disease"},{"id":"T110","span":{"begin":814,"end":820},"obj":"Disease"}],"attributes":[{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0007263"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T224","span":{"begin":236,"end":237},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T225","span":{"begin":255,"end":262},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T226","span":{"begin":481,"end":483},"obj":"http://purl.obolibrary.org/obo/CLO_0009141"},{"id":"T227","span":{"begin":481,"end":483},"obj":"http://purl.obolibrary.org/obo/CLO_0050980"},{"id":"T228","span":{"begin":610,"end":611},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T229","span":{"begin":840,"end":841},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T272","span":{"begin":208,"end":215},"obj":"Chemical"},{"id":"T273","span":{"begin":255,"end":262},"obj":"Chemical"},{"id":"T274","span":{"begin":481,"end":483},"obj":"Chemical"}],"attributes":[{"id":"A272","pred":"chebi_id","subj":"T272","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A273","pred":"chebi_id","subj":"T273","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A274","pred":"chebi_id","subj":"T274","obj":"http://purl.obolibrary.org/obo/CHEBI_141393"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T145","span":{"begin":0,"end":75},"obj":"Sentence"},{"id":"T146","span":{"begin":76,"end":305},"obj":"Sentence"},{"id":"T147","span":{"begin":306,"end":606},"obj":"Sentence"},{"id":"T148","span":{"begin":607,"end":768},"obj":"Sentence"},{"id":"T149","span":{"begin":769,"end":920},"obj":"Sentence"},{"id":"T150","span":{"begin":921,"end":1153},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T34","span":{"begin":481,"end":501},"obj":"Phenotype"},{"id":"T35","span":{"begin":502,"end":523},"obj":"Phenotype"},{"id":"T36","span":{"begin":584,"end":600},"obj":"Phenotype"},{"id":"T37","span":{"begin":728,"end":733},"obj":"Phenotype"},{"id":"T38","span":{"begin":752,"end":762},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0012251"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0001658"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0001677"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0011675"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T787","span":{"begin":27,"end":35},"obj":"SP_7"},{"id":"T788","span":{"begin":55,"end":62},"obj":"UBERON:0000948"},{"id":"T789","span":{"begin":134,"end":142},"obj":"SP_7"},{"id":"T790","span":{"begin":197,"end":215},"obj":"PR:000005897"},{"id":"T791","span":{"begin":277,"end":287},"obj":"UBERON:0002349"},{"id":"T792","span":{"begin":363,"end":370},"obj":"UBERON:0000948"},{"id":"T793","span":{"begin":502,"end":512},"obj":"UBERON:0002349"},{"id":"T794","span":{"begin":538,"end":545},"obj":"UBERON:0000948"},{"id":"T795","span":{"begin":584,"end":592},"obj":"UBERON:0001621"},{"id":"T796","span":{"begin":646,"end":654},"obj":"SP_7"},{"id":"T797","span":{"begin":700,"end":710},"obj":"UBERON:0002349"},{"id":"T798","span":{"begin":806,"end":813},"obj":"UBERON:0000948"},{"id":"T799","span":{"begin":855,"end":860},"obj":"GO:0016265"},{"id":"T800","span":{"begin":1092,"end":1106},"obj":"UBERON:0004535"},{"id":"T801","span":{"begin":1141,"end":1152},"obj":"NCBITaxon:11118"},{"id":"T74256","span":{"begin":154,"end":159},"obj":"GO:0016265"},{"id":"T20349","span":{"begin":388,"end":402},"obj":"UBERON:0004535"},{"id":"T79848","span":{"begin":437,"end":448},"obj":"NCBITaxon:11118"},{"id":"T82178","span":{"begin":465,"end":473},"obj":"SP_7"},{"id":"T45","span":{"begin":27,"end":35},"obj":"SP_7"},{"id":"T46","span":{"begin":55,"end":62},"obj":"UBERON:0000948"},{"id":"T2470","span":{"begin":105,"end":112},"obj":"UBERON:0000948"},{"id":"T26035","span":{"begin":568,"end":572},"obj":"G_3;PG_10;PR:000003622"},{"id":"T10049","span":{"begin":573,"end":583},"obj":"GO:0065007"},{"id":"T65218","span":{"begin":632,"end":641},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T55523","span":{"begin":710,"end":718},"obj":"SP_7"},{"id":"T53933","span":{"begin":762,"end":770},"obj":"SP_7"},{"id":"T49807","span":{"begin":775,"end":782},"obj":"SP_7"},{"id":"T79663","span":{"begin":814,"end":828},"obj":"DG_37;PR:000036009"},{"id":"T15361","span":{"begin":870,"end":878},"obj":"SP_7"},{"id":"T52890","span":{"begin":988,"end":996},"obj":"CHEBI:6541;CHEBI:6541"},{"id":"T87551","span":{"begin":1029,"end":1037},"obj":"SP_7"},{"id":"T34732","span":{"begin":1066,"end":1074},"obj":"SP_7"},{"id":"T23219","span":{"begin":1132,"end":1142},"obj":"GO:0040011"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1021","span":{"begin":197,"end":215},"obj":"Gene"},{"id":"1022","span":{"begin":110,"end":118},"obj":"Species"},{"id":"1023","span":{"begin":152,"end":160},"obj":"Species"},{"id":"1024","span":{"begin":338,"end":346},"obj":"Species"},{"id":"1025","span":{"begin":632,"end":640},"obj":"Species"},{"id":"1026","span":{"begin":785,"end":793},"obj":"Species"},{"id":"1027","span":{"begin":1075,"end":1083},"obj":"Species"},{"id":"1028","span":{"begin":1135,"end":1152},"obj":"Species"},{"id":"1029","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"1030","span":{"begin":55,"end":74},"obj":"Disease"},{"id":"1031","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"1032","span":{"begin":277,"end":294},"obj":"Disease"},{"id":"1033","span":{"begin":409,"end":430},"obj":"Disease"},{"id":"1034","span":{"begin":436,"end":456},"obj":"Disease"},{"id":"1035","span":{"begin":502,"end":523},"obj":"Disease"},{"id":"1036","span":{"begin":561,"end":600},"obj":"Disease"},{"id":"1037","span":{"begin":646,"end":654},"obj":"Disease"},{"id":"1038","span":{"begin":700,"end":717},"obj":"Disease"},{"id":"1039","span":{"begin":728,"end":733},"obj":"Disease"},{"id":"1040","span":{"begin":752,"end":762},"obj":"Disease"},{"id":"1041","span":{"begin":806,"end":820},"obj":"Disease"},{"id":"1042","span":{"begin":855,"end":860},"obj":"Disease"},{"id":"1043","span":{"begin":1092,"end":1113},"obj":"Disease"}],"attributes":[{"id":"A1021","pred":"tao:has_database_id","subj":"1021","obj":"Gene:1401"},{"id":"A1022","pred":"tao:has_database_id","subj":"1022","obj":"Tax:9606"},{"id":"A1023","pred":"tao:has_database_id","subj":"1023","obj":"Tax:9606"},{"id":"A1024","pred":"tao:has_database_id","subj":"1024","obj":"Tax:9606"},{"id":"A1025","pred":"tao:has_database_id","subj":"1025","obj":"Tax:9606"},{"id":"A1026","pred":"tao:has_database_id","subj":"1026","obj":"Tax:9606"},{"id":"A1027","pred":"tao:has_database_id","subj":"1027","obj":"Tax:9606"},{"id":"A1028","pred":"tao:has_database_id","subj":"1028","obj":"Tax:2697049"},{"id":"A1029","pred":"tao:has_database_id","subj":"1029","obj":"MESH:C000657245"},{"id":"A1030","pred":"tao:has_database_id","subj":"1030","obj":"MESH:D006331"},{"id":"A1031","pred":"tao:has_database_id","subj":"1031","obj":"MESH:C000657245"},{"id":"A1032","pred":"tao:has_database_id","subj":"1032","obj":"MESH:D009202"},{"id":"A1033","pred":"tao:has_database_id","subj":"1033","obj":"MESH:D059787"},{"id":"A1034","pred":"tao:has_database_id","subj":"1034","obj":"MESH:D006331"},{"id":"A1035","pred":"tao:has_database_id","subj":"1035","obj":"MESH:D009203"},{"id":"A1036","pred":"tao:has_database_id","subj":"1036","obj":"MESH:D003324"},{"id":"A1037","pred":"tao:has_database_id","subj":"1037","obj":"MESH:C000657245"},{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"MESH:D009202"},{"id":"A1039","pred":"tao:has_database_id","subj":"1039","obj":"MESH:D012769"},{"id":"A1040","pred":"tao:has_database_id","subj":"1040","obj":"MESH:D001145"},{"id":"A1041","pred":"tao:has_database_id","subj":"1041","obj":"MESH:D006331"},{"id":"A1042","pred":"tao:has_database_id","subj":"1042","obj":"MESH:D003643"},{"id":"A1043","pred":"tao:has_database_id","subj":"1043","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}

    2_test

    {"project":"2_test","denotations":[{"id":"32305401-31986264-55252981","span":{"begin":296,"end":297},"obj":"31986264"}],"text":"Several reports have noted COVID-19 is associated with cardiac involvement. In cohort studies of hospitalized patients with confirmed COVID-19, several patients presented with elevated troponin I, C-reactive protein, and N-terminal pro–B-type natriuretic peptide suggestive of myocardial injury (2,59,60). Anecdotal studies have reported patients presenting with cardiac magnetic resonance imagining−verified acute myopericarditis with systolic dysfunction masquerading as diffuse ST-segment elevation myocardial infarction with elevated cardiac markers in the absence of obstructive coronary disease (59). In a cohort study of 139 patients with COVID-19 hospitalized in Wuhan, China, 7.2% had acute myocardial injury, 8.7% had shock, and 16.7% had an arrhythmia (61). Of the observed patients, those with cardiac injury were found to have a high risk of death both from time of symptom onset and time of admission (60). As more epidemiological studies emerge from China, Italy, and other affected areas, more data will be available to elucidate the clinical presentation of patients and the cardiovascular damage associated with this novel coronavirus."}